Finance

Beta
Lists
SION:NASDAQ
Sionna Therapeutics Inc
$42.77
+4.09%
(+1.68) 1D
$42.77
0.00% (0.00)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SION...
Open
$41.09
High
$44.30
Low
$40.44
Mkt. cap
1.93B
Avg. vol.
386.96K
Volume
475.58K
52-wk high
$48.44
52-wk low
$14.34
EPS
-$1.92
Shares outstanding
45.15M
No. of employees
59
Open
$41.09
High
$44.30
Low
$40.44
Mkt. cap
1.93B
Avg. vol.
386.96K
Volume
475.58K
52-wk high
$48.44
52-wk low
$14.34
EPS
-$1.92
Shares outstanding
45.15M
No. of employees
59
News stories
From sources across the web
About Sionna Therapeutics Inc
CEO-
Employees59
Founded2019
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitesionnatx.com
Analyst ratings
Based on 9 analysts giving stock ratings to SION in the past 3 months
Buy
Buy
7
Hold
1
Sell
1
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SION in the last 3 months.
Highest
Current $42.77
$63.00 (+47.30%)
Average
$51.71 (+20.90%)
Lowest
$23.00 (-46.22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
$63.00
+47.3%
06/25/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$50.00
+16.9%
06/23/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
$60.00
+40.3%
06/22/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$55.00
+28.6%
05/25/2026
Ilya Zubkov
Freedom Capital Markets
Hold
Downgraded
-
-
05/20/2026
Laura Chico
Wedbush
Buy
Maintained
$53.00
+23.9%
05/18/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/13/2026
Kambiz Yazdi
BTIG
Buy
Reiterated
$58.00
+35.6%
05/12/2026
Brian Abrahams
RBC Capital
Sell
Maintained
$23.00
-46.2%
05/12/2026
Jonathan Wolleben
Citizens JMP
Buy
Initiated
$63.00
+47.3%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.38M
16.04M
15.17M
18.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.52M
7.76M
8.44M
10.64M
Operating expense
21.91M
23.80M
23.61M
29.60M
Total operating expenses
21.91M
23.80M
23.61M
29.60M
Operating income
-21.91M
-23.80M
-23.61M
-29.60M
Other non operating income
171.00K
71.00K
-
-
EBT including unusual items
-18.07M
-20.28M
-20.44M
-26.78M
EBT excluding unusual items
-18.07M
-20.28M
-20.44M
-26.78M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-18.07M
-20.28M
-20.44M
-26.78M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.46
-0.46
-0.60
Interest and investment income
3.67M
3.46M
3.17M
2.82M
Interest expense
-
-
-
-
Net interest expenses
3.67M
3.46M
3.17M
2.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.76M
-23.62M
-23.46M
-29.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of SION
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer